OverviewSuggest Edit

OMass Therapeutics is a biotechnology company using structural mass spectrometry to discover novel medicines. The technology enables the detection of drug leads that not only bind to the target complex but also exert a functional effect through modulation of complex formation, with both effects, binding and function, being measured by a change in mass.
TypePrivate
Founded2016
HQOxford, GB
Websiteomass.com

Locations

OMass Therapeutics is headquartered in
Oxford, United Kingdom

Location Map

Latest Updates

Employees (est.) (Feb 2020)21(+5%)
Revenue (FY, 2018)£396.6 K(+38%)

Key People/Management at OMass Therapeutics

Rosamond Deegan

Rosamond Deegan

Chief Executive Officer, Diretor
Ali Jazayeri

Ali Jazayeri

Chief Scientific Officer
Jonathan Hopper

Jonathan Hopper

Vice President, Platforms and Founder
Idlir Liko

Idlir Liko

Director of Technology and Founder
Hsin Loke

Hsin Loke

Vice President, Head of Finance and Strategy
Giles Brown

Giles Brown

Vice President, Medicinal Chemistry
Show more

OMass Therapeutics Office Locations

OMass Therapeutics has an office in Oxford
Oxford, GB (HQ)
Heatley Rd, The Oxford Science Park
Show all (1)

OMass Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2016

OMass Therapeutics total Funding

$19.3 m

OMass Therapeutics latest funding size

$17.90 m

Time since last funding

a year ago

OMass Therapeutics investors

OMass Therapeutics's latest funding round in November 2018 was reported to be $17.9 m. In total, OMass Therapeutics has raised $19.3 m
Show all financial metrics

OMass Therapeutics Revenue

Embed Graph
View revenue for all periods
OMass Therapeutics's revenue was reported to be £396.63 k in FY, 2018
GBP

Revenue (FY, 2018)

396.6k

Gross profit (FY, 2018)

257.9k

Gross profit margin (FY, 2018), %

65%

Net income (FY, 2018)

(1.2m)

EBIT (FY, 2018)

(1.3m)

Cash (31-Dec-2018)

4.0m
GBPFY, 2017FY, 2018

Revenue

287.6k396.6k

Cost of goods sold

65.2k138.8k

Gross profit

222.4k257.9k

Gross profit Margin, %

77%65%
GBPFY, 2016FY, 2017FY, 2018

Cash

762.3k494.7k4.0m

Accounts Receivable

238.0k

Current Assets

796.0k789.1k4.5m
GBPY, 2018

Financial Leverage

1.3 x
Show all financial metrics

OMass Therapeutics Online and Social Media Presence

Embed Graph

OMass Therapeutics Frequently Asked Questions

  • When was OMass Therapeutics founded?

    OMass Therapeutics was founded in 2016.

  • Who are OMass Therapeutics key executives?

    OMass Therapeutics's key executives are Rosamond Deegan, Ali Jazayeri and Jonathan Hopper.

  • How many employees does OMass Therapeutics have?

    OMass Therapeutics has 21 employees.

  • What is OMass Therapeutics revenue?

    Latest OMass Therapeutics annual revenue is £396.6 k.

  • What is OMass Therapeutics revenue per employee?

    Latest OMass Therapeutics revenue per employee is £18.9 k.

  • Who are OMass Therapeutics competitors?

    Competitors of OMass Therapeutics include Dermala, Frequency Therapeutics and Vividion Therapeutics.

  • Where is OMass Therapeutics headquarters?

    OMass Therapeutics headquarters is located at Heatley Rd, The Oxford Science Park, Oxford.

  • Where are OMass Therapeutics offices?

    OMass Therapeutics has an office in Oxford.

  • How many offices does OMass Therapeutics have?

    OMass Therapeutics has 1 office.